These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2995706)

  • 1. Antibody to lymphadenopathy-associated virus in two Japanese hemophiliacs.
    Sugiyama H; Katamine S; Tsuji Y; Yanai M; Hino S; Miyamoto T
    Jpn J Exp Med; 1985 Apr; 55(2):79-80. PubMed ID: 2995706
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
    McFadden T; Jason JM; Feorino P
    JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
    Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
    Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state].
    Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F
    Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
    Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
    AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain.
    Kitchen L; Leal M; Wichmann I; Lissen E; Ollero M; Allan JS; McLane MF; Essex M
    Blood; 1985 Dec; 66(6):1473-5. PubMed ID: 2998515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 11. LAV/HTLV III presence in peripheral blood lymphocytes of seropositive young hemophiliacs.
    Gomperts ED; Feorino P; Evatt BL; Warfield D; Miller R; McDougal JS
    Blood; 1985 Jun; 65(6):1549-52. PubMed ID: 2986748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.
    Rouzioux C; Brun-Vezinet F; Couroucé AM; Gazengel C; Vergoz D; Desmyter J; Vermylen J; Vermylen C; Klatzmann D; Geroldi D
    Ann Intern Med; 1985 Apr; 102(4):476-9. PubMed ID: 2983593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-LAV and concentrate consumption in Italian hemophiliacs.
    Mannucci PM; Ammassari M; Gringeri A; Geroldi D; Zanetti AR
    Thromb Haemost; 1985 Aug; 54(2):556. PubMed ID: 3001966
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of anti-oncogenic virus antibodies in patients with malignancies, hemophilia and systemic lupus erythematosus.
    Lin KT; Liu MF; Hsieh RP; Lynn TC; Shen MC; Wang JH; Chen YC; Lai MY; Chen DS; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1985 Sep; 84(9):1025-32. PubMed ID: 3005471
    [No Abstract]   [Full Text] [Related]  

  • 17. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(26):421-4. PubMed ID: 3014305
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
    Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
    Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
    Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
    Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E
    Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.